Association between Serum Uric Acid and Mortality among Chinese Patients with Coronary Artery Disease

Objectives: Several studies have investigated the association between serum uric acid (SUA) and the risks of coronary artery disease (CAD) but have yielded inconsistent results. The aim of this study was to assess whether there is an independent association of SUA with all-cause and cardiovascular disease (CVD) mortality in Chinese patients with CAD. Methods: A prospective cohort study of 1,799 patients was conducted. Cox regression models were used to estimate the association of SUA with the risk of death. Results: During a median follow-up of 3.9 years, 177 deaths were recorded and 126 of these were due to CVD. Patients in the highest SUA quartile had a 2.43-fold risk of all-cause mortality and a 2.44-fold risk of CVD mortality compared with those in the lowest quartile. In the subpopulation analysis, the association between SUA and mortality remained similar when participants were stratified by age, gender, body mass index and type of CAD. In contrast, we found a significant interaction with estimated glomerular filtration rate (eGFR). There was a stronger association between SUA and the risk of all-cause and CVD mortality among patients with an eGFR ≥60 ml/min/1.73 m2, but no significant association was found in the population with an eGFR <60 ml/min/1.73 m2. Conclusions: Elevated SUA levels were positively associated with an increased risk of all-cause and CVD mortality among CAD patients.

[1]  D. Atar,et al.  Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative , 2015, European journal of heart failure.

[2]  Matthew J. Crowley,et al.  Patient-reported medication adherence barriers among patients with cardiovascular risk factors. , 2015, Journal of managed care & specialty pharmacy.

[3]  Y. Kanno,et al.  Uric Acid Level Has a U-Shaped Association with Loss of Kidney Function in Healthy People: A Prospective Cohort Study , 2015, PloS one.

[4]  D. Corella,et al.  Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  G. Gensini,et al.  Uric acid and mild renal impairment in patients with ST-elevation myocardial infarction , 2015, Scandinavian cardiovascular journal : SCJ.

[6]  J. Wang,et al.  Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies , 2014, PloS one.

[7]  J. Ryoo,et al.  Serum Uric Acid Level and the Incidence of Metabolic Syndrome in Middle-aged Korean Men: A 5-Year Follow-up Study , 2014, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[8]  C. Borghi,et al.  Hyperuricemia and cardiovascular disease risk , 2014, Expert review of cardiovascular therapy.

[9]  I. Ben-Zvi,et al.  Serum Uric Acid Is Associated With Coronary Artery Calcification , 2014, Journal of clinical hypertension.

[10]  G. Hu,et al.  Hyperglycemia and Mortality Among Patients With Coronary Artery Disease , 2014, Diabetes Care.

[11]  S. Chadban,et al.  Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study , 2013, BMC Cardiovascular Disorders.

[12]  A. Kastrati,et al.  A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[13]  Y. Zhang,et al.  The Prevalence and Awareness of Cardiometabolic Risk Factors in Southern Chinese Population with Coronary Artery Disease , 2013, TheScientificWorldJournal.

[14]  Kai Huang,et al.  High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies , 2013, PloS one.

[15]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[16]  M. Hadamitzky,et al.  Association of uric acid with mortality in patients with stable coronary artery disease. , 2012, Metabolism: clinical and experimental.

[17]  M. Hadamitzky,et al.  Prognostic value of uric acid in patients with acute coronary syndromes. , 2012, The American journal of cardiology.

[18]  Yan V. Sun,et al.  Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition. , 2012, Revista panamericana de salud publica = Pan American journal of public health.

[19]  D. Sica Diuretic use in renal disease , 2012, Nature Reviews Nephrology.

[20]  Jianlin Du,et al.  Clinical analysis of the risk factors of slow coronary flow , 2011, Heart and Vessels.

[21]  A. Oto,et al.  Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography. , 2010, Atherosclerosis.

[22]  A. Rule,et al.  The association of serum uric acid levels with outcomes following percutaneous coronary intervention. , 2010, Journal of interventional cardiology.

[23]  Yu-ming Chen,et al.  Validation of an FFQ to estimate the intake of fatty acids using erythrocyte membrane fatty acids and multiple 3d dietary records , 2009, Public Health Nutrition.

[24]  I. Holme,et al.  Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) , 2009, Journal of internal medicine.

[25]  H. Yip,et al.  Uric Acid is not an independent predictor of cardiovascular death in patients with angiographically proven coronary artery disease. , 2009, Chang Gung medical journal.

[26]  P Michael Ho,et al.  Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.

[27]  J. Higaki,et al.  Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[28]  S. Navaneethan,et al.  Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  G. Lippi,et al.  The paradoxical relationship between serum uric acid and cardiovascular disease. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[30]  K. Pfeiffer,et al.  Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. , 2008, International journal of cardiology.

[31]  B. Hoogwerf,et al.  Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. , 2008, Arthritis and rheumatism.

[32]  P. Vokonas,et al.  Uric Acid and the Development of Hypertension: The Normative Aging Study , 2006, Hypertension.

[33]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[34]  C. Tei,et al.  Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). , 2005, The American journal of cardiology.

[35]  J. Danesh,et al.  Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis , 2005, PLoS medicine.

[36]  J. Critchley,et al.  Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999 , 2004, Circulation.

[37]  Y. Moriwaki,et al.  Effect of beer on the plasma concentrations of uridine and purine bases. , 2002, Metabolism: clinical and experimental.

[38]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[39]  F Santeusanio,et al.  Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study , 2000, Hypertension.

[40]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Circulation.

[41]  A. Folsom,et al.  Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. , 2000, Annals of epidemiology.

[42]  Sankey V. Williams,et al.  ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). , 1999, Circulation.

[43]  P. Whincup,et al.  Serum urate and the risk of major coronary heart disease events. , 1997, Heart.

[44]  P. Wickramaratne Sample size determination in epidemiologic studies , 1995, Statistical methods in medical research.

[45]  R. Dean,et al.  Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[46]  T. Byers,et al.  Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. , 1995, American journal of epidemiology.

[47]  M. Brodie,et al.  Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. , 1990, BMJ.

[48]  T. Gordon,et al.  Some factors related to coronary heart disease incidence in Honolulu Japanese men: the Honolulu Heart Study. , 1975, International journal of epidemiology.

[49]  D. Kang,et al.  Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. , 2005, Seminars in nephrology.

[50]  Daniel L. McGee,et al.  Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. , 1985, American journal of epidemiology.

[51]  J. Ryoo,et al.  Association of Serum Uric Acid Level and the Development of Metabolic Syndrome in Middle-aged Korean Men : A 5-year Follow-up Study , 2022 .